Shareholding disclosure
ADDEX THERAPEUTICS LTD
Declared position
60.06%
Threshold
Crossed downwards
Timeline
Published
11.01.2022
Transaction
04.01.2022
Voting rights breakdown
Voting rights acquired23.16%
Voting rights sold60.06%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAM1600073
Beneficial owner
ADDEX THERAPEUTICS LTD
Declared address
ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES
Modification to the condition on which the ESOP/ESC have been granted. The exercise prices of 8,186,045 ESOP and 108,000 ESC have been reduced to CHF 1. Following Securities Purchase Agreement signed on December 16, 2021, all shares held in purchase position cannot be sold until March, 21 2022.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open